免疫检查点抑制剂:骨质疏松症的朋友或敌人。

IF 3.9 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Therapeutic Advances in Endocrinology and Metabolism Pub Date : 2023-01-01 DOI:10.1177/20420188231157194

Jun Tang

引用次数: 1

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Immune checkpoint inhibitors: friend or foe for osteoporosis.

查看原文本刊更多论文

Immune checkpoint inhibitors: friend or foe for osteoporosis.

maturation are favored over osteoblastogenesis, resulting in bone loss and fracture risks

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic Advances in Endocrinology and Metabolism Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

7.70

自引率

2.60%

发文量

审稿时长

8 weeks

期刊介绍： Therapeutic Advances in Endocrinology and Metabolism delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of endocrinology and metabolism.